Literature DB >> 35800750

The optimal extent of lymph node dissection in N1b papillary thyroid microcarcinoma based on clinicopathological factors and preoperative ultrasonography.

Xiao-Nan Liu1,2, Yuan-Sheng Duan1, Kai Yue1, Yan-Sheng Wu1, Wen-Chao Zhang1, Xu-Dong Wang1.   

Abstract

Background: The optimal extent of lymph node (LN) dissection in the management of N1b papillary thyroid microcarcinoma (PTMC) is still under debate in clinical practice, so we aimed to identify the risk factors associated with multilevel lateral lymph node metastasis (LLNM) with regard to the extent of LN dissection.
Methods: The clinical data of 182 N1b PTMC patients between January 2019 and June 2021 at Tianjin Medical University Cancer Institute and Hospital were retrospectively reviewed. The frequency pattern and distribution of LLNM were analyzed for risk factors. We assessed the diagnostic value of preoperative ultrasonography (USG) for identifying levels II-V metastasis in PTMC patients.
Results: The proportion of multilevel LLNM in N1b PTMC was 72.1%, and the most common pattern was metastasis at two levels (41.2%). Capsule invasion [odds ratio (OR) =6.861, 95% confidence interval (CI): 1.462-32.190, P=0.015], upper pole [OR =2.125, 95% CI: 1.010-4.473, P=0.047], central LN ratio [OR =7.315, 95% CI: 1.309-40.877, P=0.023], thyroid-stimulating hormone (TSH) >1.5 mIU/mL [OR =2.773, 95% CI: 1.269-6.060, P=0.011], and extranodal extension (ENE) [OR =2.632, 95% CI: 1.207-5.739, P=0.015] were independent risk factors for multilevel metastasis. In addition, unltrasonography had high sensitivity and specificity in the diagnosis of metastasis at level V (75.0%, 78.4%) and multilevel LLNM (67.2%, 64.8%). Conclusions: Modified radical neck dissection (MRND) in N1b PTMC patients may be reserved for patients with simultaneous 3-level LLNM or clinically evident metastasis at level V. Preoperative USG may have certain suggestive significance in the diagnosis of multilevel LLNM in primary PTMC. 2022 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Multilevel lateral metastasis; papillary thyroid microcarcinoma (PTMC); risk factors; ultrasonography (USG)

Year:  2022        PMID: 35800750      PMCID: PMC9253184          DOI: 10.21037/gs-22-284

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  33 in total

1.  Patterns, predictive factors and prognostic impact of multilevel metastasis in N1b papillary thyroid carcinoma.

Authors:  S K Kim; I Park; N Hur; J-H Choe; J-H Kim; J S Kim
Journal:  Br J Surg       Date:  2017-03-15       Impact factor: 6.939

2.  Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases.

Authors:  Xiao-Min Yu; Yin Wan; Rebecca S Sippel; Herbert Chen
Journal:  Ann Surg       Date:  2011-10       Impact factor: 12.969

3.  Papillary microcarcinoma of the thyroid: how should it be treated?

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

4.  Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer.

Authors:  Abbas Ali Tam; Didem Ozdemir; Cevdet Aydın; Nagihan Bestepe; Serap Ulusoy; Nuran Sungu; Reyhan Ersoy; Bekir Cakir
Journal:  Endocrine       Date:  2018-01-27       Impact factor: 3.633

5.  Surgical treatment of cervical nodal metastases in patients with papillary thyroid carcinoma.

Authors:  Neil Bhattacharyya
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-10

6.  Large-Volume Lateral Lymph Node Metastasis Predicts Worse Prognosis in Papillary Thyroid Carcinoma Patients With N1b.

Authors:  Luying Gao; Xiaoyi Li; Yu Xia; Ruifeng Liu; Chunhao Liu; Xinlong Shi; Yanjiao Wu; Liyuan Ma; Yuxin Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-02       Impact factor: 5.555

7.  Predictive Value of Gross Extranodal Extension for Differentiated Thyroid Carcinoma Persistence/Recurrence.

Authors:  Ying Kou; Guohua Shen; Zhuzhong Cheng; Anren Kuang
Journal:  Otolaryngol Head Neck Surg       Date:  2021-06-29       Impact factor: 3.497

8.  Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases.

Authors:  Jing Yang; Yanping Gong; Shuping Yan; Jingqiang Zhu; Zhihui Li; Rixiang Gong
Journal:  Cancer Med       Date:  2016-07-01       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.